Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"
about
Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophyZellweger spectrum disorders: clinical overview and management approachABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlationsX-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.Therapy of X-linked adrenoleukodystrophySeven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy.Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy.Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans.Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure.Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins: implications for adrenoleukodystrophy.Advances and pitfalls of cell therapy in metabolic leukodystrophies.X-linked adrenoleukodystrophy: pathogenesis and treatment.A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study.Uptake and metabolism of plasma-derived erucic acid by rat brain.A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila.
P2860
Q24618949-7C5ED640-42AF-4490-A356-8685B05D0458Q26775566-E48A5483-EDF5-4EF3-904B-36AC02877EE2Q28211918-049AAE60-BC02-4A45-BBB3-5B0E24E43BEEQ30460666-7302DB56-9E5D-4E72-A4E6-CCAF02B0019AQ31034858-C9FB25C6-4D16-4FF2-9BB1-97317F5BBD37Q33693068-2F6D6749-3009-48FB-B5F7-53162A05788DQ33882324-31D2BEBE-8CB2-4EC8-8052-B037CA3397C1Q34025017-957306EE-80D8-4719-866E-1120567D76D7Q34049839-3194EA5C-ACA5-409F-A262-4FD4A6A827FEQ34513788-7F081E36-C1EE-48CB-A6EC-154F49222797Q35225619-A4107B7C-AFD1-4220-93EF-760E16AA1C95Q36315284-8A650D8F-DB46-43A4-AB45-65424D62A111Q36743396-42CAC0E0-2DBA-41AA-969C-A7DA1E223D94Q37446137-7A78676C-4763-449B-A0BC-A4A7BDD78222Q38046023-D5FA5832-1D78-4730-8E37-340C68D9D835Q38239213-F7EEF5B0-7D1F-420A-8CBC-91A0AE7C78BDQ38829141-9C7FA8D0-6BBB-4713-822E-544B2CD3D96DQ38867787-53DF2C61-4433-47FD-B457-B0F8F090CE59Q41713441-4D5468DC-75F3-4F93-A10E-B7A6CC4B10D6Q46981518-2AA93A11-53E4-4C64-93AB-EF3F736F114EQ47801072-DBD96429-BA53-4D1A-BCC3-547D0BD0FA1CQ55055706-25AF9DE8-E194-4450-AD26-77490952835CQ55519024-3513546E-D49F-40F7-949A-6325609FB047
P2860
Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@ast
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@en
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@nl
type
label
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@ast
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@en
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@nl
prefLabel
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@ast
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@en
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@nl
P2093
P2860
P356
P1476
Progression of abnormalities i ...... treatment with "Lorenzo's oil"
@en
P2093
B M van Geel
B Verbeeten
E B Haverkort
J H Koelman
R J Wanders
P2860
P356
10.1136/JNNP.67.3.290
P407
P577
1999-09-01T00:00:00Z